Generic

This Is how Teva and 19 of its Rivals Fixed U.S. Drug Prices

15.05.19 | Hezi Sternlicht, Ran Abramson, and Tomer Ganon

FDA Approves Teva’s Generic Nasal Spray for Opioid Overdose

21.04.19 | Lilach Baumer

Copaxone Profit will Continue to Fall, But Teva is Set to Double Down on Biosimilars

08.01.19 | Lilach Baumer and Hezi Sternlicht

Teva Reaches Confidential Patent Settlement with Neos

27.12.18 | CTech

Teva, Mylan Drop on Announcement of Epinephrine Injector Rival

09.12.18 | Lilach Baumer

Teva's Swiss Anti-Nausea Drug Patent Suit Reaches U.S. Supreme Court

05.12.18 | Lilach Baumer

Teva, Celltrion Gain FDA Approval for Generic Blood Cancer Bio-Drug

29.11.18 | Lilach Baumer

Teva's American Dream Boat is Sinking

08.08.18 | Uri Tal-Tene

Court Rules Allergan Can't Use Indian Tribe Deal to Protect Patents

23.07.18 | CTech

Teva Increases Junk Senior Note Offering to $4.5 Billion

08.03.18 | Lilach Baumer

Berkshire Hathaway Takes Position in Generic Drugmaker Teva

15.02.18 | Lilach Baumer

Teva in Talks to Appoint AstraZenca's Pascal Soriot as CEO

18.07.17 | Golan Hazani